ID   HLCZ01
AC   CVCL_1J92
DR   Wikidata; Q54889846
RX   Patent=US9989520;
RX   PubMed=24616513;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201309.
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
RX   PubMed=24616513; DOI=10.1073/pnas.1320071111; PMCID=PMC3977290;
RA   Yang, Da-Rong
RA   Zuo, Chao-Hui
RA   Wang, Xiao-Hong
RA   Meng, Xiang-He
RA   Xue, Bin-Bin
RA   Liu, Nian-Li
RA   Yu, Rong
RA   Qin, Yu-Wen
RA   Gao, Yi-Min
RA   Wang, Qiu-Ping
RA   Hu, Jun
RA   Wang, Ling
RA   Zhou, Ze-Bin
RA   Liu, Bing
RA   Tan, De-Ming
RA   Guan, Yang
RA   Zhu, Hai-Zhen
RT   "Complete replication of hepatitis B virus and hepatitis C virus in a
RT   newly developed hepatoma cell line.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:E1264-E1273(2014).
//
RX   Patent=US9989520;
RA   Zhu, Hai-Zhen
RA   Zuo, Chao-Hui
RA   Wang, Xian-Hong
RA   Yang, Da-Rong
RA   Liu, Nian-Li
RT   "Human hepatoma cell line HLCZ01 and uses thereof.";
RL   Patent number US9989520, 05-Jun-2018.
//